Uveal melanoma: epidemiologic aspects N Singh, L Bergman, S Seregard, AD Singh Clinical Ophthalmic Oncology, 75-87, 2014 | 428 | 2014 |
Metrics for monitoring cancer inequities: residential segregation, the Index of Concentration at the Extremes (ICE), and breast cancer estrogen receptor status (USA, 1992–2012) N Krieger, N Singh, PD Waterman Cancer Causes & Control 27 (9), 1139-1151, 2016 | 69 | 2016 |
Retinoblastoma: a SEER dataset evaluation for treatment patterns, survival, and second malignant neoplasms D Tamboli, A Topham, N Singh, AD Singh American journal of ophthalmology 160 (5), 953-958, 2015 | 50 | 2015 |
Iodine-125 brachytherapy for uveal melanoma: a systematic review of radiation dose JJ Echegaray, NE Bechrakis, N Singh, C Bellerive, AD Singh Ocular oncology and pathology 3 (3), 193-198, 2017 | 44 | 2017 |
Vision loss following episcleral brachytherapy for uveal melanoma: development of a vision prognostication tool HA Aziz, N Singh, J Bena, A Wilkinson, AD Singh JAMA ophthalmology 134 (6), 615-620, 2016 | 43 | 2016 |
Prevalence and causes of blindness and visual impairment and their associated risk factors, in three tribal areas of Andhra Pradesh, India N Singh, SS Eeda, BK Gudapati, S Reddy, P Kanade, GPS Shantha, ... PLoS One 9 (7), e100644, 2014 | 39 | 2014 |
Health and human rights in eastern Myanmar after the political transition: a population-based assessment using multistaged household cluster sampling PK Parmar, CC Barina, S Low, KT Tun, C Otterness, PP Mhote, SN Htoo, ... PloS one 10 (5), e0121212, 2015 | 36 | 2015 |
Validation of the rapid test Carestart (tm) G6PD among malaria vivax-infected subjects in the Brazilian Amazon MAM Brito, HM Peixoto, ACG Almeida, MRF Oliveira, GAS Romero, ... Revista da Sociedade Brasileira de Medicina Tropical 49, 446-455, 2016 | 32 | 2016 |
Extranodal marginal zone lymphoma of ocular adnexa: outcomes following radiation therapy S Platt, Y Al Zahrani, N Singh, B Hill, S Cherian, AD Singh Ocular oncology and pathology 3 (3), 181-187, 2017 | 29 | 2017 |
Diagnostic cytologic features of uveal melanoma CA Medina, CV Biscotti, N Singh, AD Singh Ophthalmology 122 (8), 1580-1584, 2015 | 23 | 2015 |
Inferring an evolutionary tree of uveal melanoma from genomic copy number aberrations N Singh, AD Singh, W Hide Investigative ophthalmology & visual science 56 (11), 6801-6809, 2015 | 22 | 2015 |
Uveal melanoma in BAP1 tumor predisposition syndrome: estimation of risk N Singh, R Singh, RC Bowen, MH Abdel-Rahman, AD Singh American Journal of Ophthalmology 224, 172-177, 2021 | 19 | 2021 |
Maintaining interrater agreement of core assessment instruments in a multisite randomized controlled clinical trial: The Randomized Evaluation of Sedation Titration for … R Lebet, J Hayakawa, TB Chamblee, JA Tala, N Singh, D Wypij, ... Nursing research 66 (4), 323, 2017 | 15 | 2017 |
Uveal melanoma regression after brachytherapy: relationship with chromosome 3 monosomy status SM Salvi, HA Aziz, S Dar, N Singh, B Hayden-Loreck, AD Singh Ocular oncology and pathology 3 (2), 87-94, 2017 | 13 | 2017 |
Diagnostic A-scan of choroidal tumors: comparison of quantified parameters N Singh, Y Fonkeu, BH Lorek, AD Singh Ocular oncology and pathology 5 (5), 358-368, 2019 | 9 | 2019 |
The Amazon Ocular Oncology Center: The first three years S Cohen, CS Pretyman, R Sant’Ana, N Singh, M Morales, RN Belfort Arquivos brasileiros de oftalmologia 82, 107-110, 2019 | 8 | 2019 |
Fine-needle aspiration biopsy for suspected uveal metastases C Bellerive, CV Biscotti, N Singh, AD Singh Canadian Journal of Ophthalmology 54 (6), 694-698, 2019 | 6 | 2019 |
Uveal melanoma: Epidemiologic aspects N Singh, S Seregard, AD Singh Clinical Ophthalmic Oncology, 53-69, 2019 | 6 | 2019 |
Principles of Cancer Epidemiology AC Moll, MR de Boer, LM Bouter, N Singh Clinical Ophthalmic Oncology: Basic Principles, 1-10, 2019 | 4 | 2019 |
Diagnostic A-scan of choroidal melanoma: automated quantification of parameters Y Fonkeu, N Singh, B Hayden-Loreck, AD Singh Ocular oncology and pathology 5 (5), 350-357, 2019 | 3 | 2019 |